Organoids are tiny, three-dimensional tissue structures grown in the lab from stem cells. They self-organize to mimic the architecture and function of real organs, earning them nicknames like “mini-brains” or “mini-guts.” Ranging from the size of a grain of sand to a few millimeters across, they serve as living models for studying human disease, testing drugs, and exploring how organs develop.
How Organoids Differ From Traditional Cell Cultures
For decades, scientists studied human cells by growing them in flat layers on plastic dishes. These two-dimensional cultures are useful but limited: cells grown flat lose key characteristics they have inside the body, including their natural shape, polarity, and metabolic behavior. Most importantly, flat cultures can’t recreate the cell-to-cell and cell-to-tissue interactions that drive how real organs work.
Organoids solve this by growing in three dimensions, allowing cells to arrange themselves into structures that resemble actual organ tissue. An intestinal organoid, for example, forms tiny crypt-and-villus shapes just like the lining of your gut, complete with the major cell types found there: nutrient-absorbing enterocytes, mucus-producing goblet cells, hormone-secreting enteroendocrine cells, and Paneth cells that help regulate the stem cell population. This level of structural realism bridges the gap between what happens in a lab dish and what happens inside a living body.
How Organoids Are Grown
Organoids start with stem cells, which can come from two main sources. The first is induced pluripotent stem cells (iPSCs), ordinary cells (often skin or blood cells) that have been reprogrammed back into a flexible stem cell state. iPSCs can theoretically become any tissue type, making them useful for modeling a wide range of organs and developmental stages. The second source is adult stem cells taken directly from a patient’s tissue through a biopsy. These adult stem cell organoids faithfully recreate the characteristics and disease features of the tissue they came from.
Once you have the right stem cells, they need a physical scaffold to grow on. Most labs use a gel-like substance called Matrigel, a protein-rich matrix containing structural proteins and growth factors that provides the three-dimensional support cells need to self-organize. Researchers are also developing alternatives, including hydrogels made from the processed tissue of specific organs (liver tissue to grow liver organoids, for instance) and fully synthetic matrices that let scientists fine-tune the stiffness and composition of the growth environment. For larger-scale production, bioreactor systems use rotational forces to distribute nutrients evenly, producing more uniform organoids in greater quantities.
Types of Organoids
Brain Organoids
Brain organoids are among the most complex and closely watched. Grown from human stem cells, they can simulate processes that occur during early brain development, including the birth of new neurons, neuronal migration, the formation of layered cortical tissue, and the establishment of basic neural circuits. Researchers have created region-specific brain organoids representing the cortex, hippocampus, thalamus, hypothalamus, midbrain, cerebellum, brainstem, and even structures related to the pituitary gland and the eye’s retina.
One powerful technique involves fusing two or more region-specific brain organoids together into “assembloids.” These fused structures let scientists watch neurons migrate between brain regions, extend projections, and generate the insulating cells that coat nerve fibers. This has made brain organoids valuable for studying neurodevelopmental disorders and testing potential treatments in a system that captures human-specific biology that animal models cannot.
Gut Organoids
Intestinal organoids, sometimes called “mini-guts,” were among the first organoid types successfully grown, and they remain one of the most well-established. They self-organize into spheres with self-renewing crypt structures and proliferative zones that produce the full range of intestinal cell types. Because they can be grown directly from patient biopsies, they’re used to study conditions like inflammatory bowel disease, celiac disease, and colorectal cancer using tissue that reflects an individual patient’s biology.
Other Organ Types
The same principles apply across many organ systems. Researchers now routinely grow organoids representing the liver, kidney, lung, pancreas, stomach, and prostate, among others. Each type recapitulates key structural and functional features of the organ it models.
Organoids in Cancer Treatment
One of the most promising applications is using patient-derived organoids to guide cancer treatment. The process works like this: a small sample of a patient’s tumor is used to grow organoids in the lab, creating a living replica of that person’s cancer. Doctors can then test multiple drugs or drug combinations on these tumor organoids to see which ones are most effective before the patient receives treatment.
The accuracy is striking. A 2018 study in Science found that organoid-based drug sensitivity testing predicted clinical responses in gastrointestinal cancer patients with 100% sensitivity and 93% specificity, meaning it correctly identified nearly every drug that would work and almost never flagged a drug that wouldn’t. More recent research on esophageal cancer reported an overall accuracy of 83.3% in predicting which patients would respond to chemotherapy, with 80% sensitivity and 85.7% specificity.
Beyond predicting drug response, tumor organoids allow researchers to study the diversity of cell types within a single tumor and examine how surrounding non-tumor cells influence cancer behavior. This makes them useful for discovering biomarkers, profiling the molecular landscape of a patient’s cancer, and testing gene-editing approaches in a preclinical setting.
The Vascularization Problem
Organoids have a fundamental size limit. Because they lack blood vessels, every cell depends on nutrients and oxygen diffusing in from the surrounding gel. That diffusion only works across a distance of a few hundred microns, roughly the width of a few sheets of paper. Beyond that range, cells starve and waste products accumulate, causing the organoid’s core to die.
This is the single biggest obstacle to growing organoids that fully replicate organ function. Organs with high metabolic demands, like the heart, liver, kidney, and brain, are especially affected. Without a functional vascular network, organoids hit a growth ceiling and can’t mature to the size or complexity of real tissue. Researchers are actively working on strategies to vascularize organoids, including co-culturing them with blood vessel cells and using microfluidic chips to simulate blood flow, but no approach has yet produced the kind of branching, functional vessel network that organs rely on in the body.
Organ-on-a-Chip Integration
A growing area of development combines organoids with microfluidic technology, tiny engineered chips with channels that pump fluid past living tissue. These “organ-on-a-chip” systems can connect multiple organoid types, creating linked networks where a liver organoid processes a drug, and the metabolized product flows to a heart or kidney organoid downstream. This mimics how your body’s organs communicate through the bloodstream.
Multi-organ-on-a-chip platforms aim to model systemic diseases that involve more than one organ, test how a drug might cause side effects in tissues beyond its target, and eventually provide personalized “body-on-a-chip” systems built from a single patient’s cells. Next-generation versions are incorporating elements of the immune system, nervous system, and vascular system, along with real-time chemical and molecular sensors that monitor tissue responses as they happen.
Ethical Considerations
Brain organoids raise unique questions. As these structures become more complex and begin forming neural circuits, researchers and ethicists have grappled with whether they could ever develop anything resembling awareness or the capacity to suffer. Current brain organoids are far from this threshold. They lack the size, organization, and sensory input of a real brain. But the International Society for Stem Cell Research has flagged organoid development as an area requiring careful ethical oversight, and its guidelines emphasize transparent review processes and strong scientific justification for experiments involving advanced stem cell models. As the technology progresses, these frameworks will need to keep pace with what organoids can actually do.